ProMIS Neurosciences Inc.
ProMIS Neurosciences is a clinical-stage biotechnology company focused on discovering and developing therapeutic antibodies that selectively target toxic oligomers associated with neurodegenerative and other misfolded protein diseases. Their proprietary EpiSelect™ platform identifies Disease Specific Epitopes (DSEs) on misfolded proteins, enabling the creation of highly selective antibodies. They are developing treatments for diseases like Alzheimer's, ALS, and Parkinson's disease, positioning themselves as innovators in precision medicine for neurodegenerative disorders.
Offisielt Register
AI Kvalitetsanalyse
Tillitsscore Detaljer
Snarveier
Nettside Høydepunkter
🌟 Lignende Pålitelige Bedrifter
SANGAMO THERAPEUTICS, INC
Sangamo Therapeutics is pioneering the future of genomic medicine, translating groundbreaking science into tomorrow’s cures. They leverage their deep scientific expertise and proprietary zinc finger platform to develop innovative therapies. The company is focused on developing treatments for genetic diseases.
uniQure N.V.
uniQure is a gene therapy company delivering potentially curative treatments through its AAV-based technology platform. They focus on developing gene therapies for diseases like hemophilia B and Huntington's disease. With approved gene therapy for hemophilia B and a growing pipeline, uniQure is positioned as a leader in genomic medicine, aiming to transform patient care with innovative cures.
Allogene Therapeutics, Inc.
Allogene Therapeutics is a clinical-stage biotechnology company focused on developing allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. They have a fully integrated team dedicated to research, development, and cell manufacturing. Their goal is to deliver "off-the-shelf" CAR T cell candidates faster and more reliably.